Featured Research

from universities, journals, and other organizations

UF Dental Researcher Develops Genetically Altered Bacteria Strain That May Fight Cavities For A Lifetime

Date:
February 9, 2000
Source:
University Of Florida Health Science Center
Summary:
Fighting tooth decay could someday be as simple as using a mouth rinse, thanks to a University of Florida researcher who has genetically altered the bacterium known to cause tooth decay into a form that may permanently prevent the disease.

GAINESVILLE, Fla. --- Fighting tooth decay could someday be as simple as using a mouth rinse, thanks to a University of Florida researcher who has genetically altered the bacterium known to cause tooth decay into a form that may permanently prevent the disease.

The friendlier version appears safe and longlasting, and apparently has a sweet tooth of its own, thriving on a high-sugar diet in the laboratory, reports UF dentist Jeffrey Hillman in the February issue of the journal Infection and Immunity. Hillman constructed a new strain of the decay-causing bacterium Streptococcus mutans for use in replacement therapy.

Streptococcus mutans, a naturally occurring bacterium found in the mouth, breaks down food sugars, resulting in the formation of lactic acid. Over time, the acid destroys tooth enamel, causing cavities.

"Based on this accepted theory of the decay process, we eliminated the gene responsible for lactic acid production from a strain of Streptococcus mutans," said Hillman, a professor of oral biology at UF's College of Dentistry. "The new strain does not produce lactic acid and therefore will not cause decay."

Hillman studied the new strain -- called an effector strain -- in the laboratory and in rat models. He found it dominated the naturally occurring bacterium and blocked it from colonizing the tooth surface.

"The effector strain didn't cause tooth decay even when the animals were fed a high-sugar diet. In fact, sugar actually helps our strain to colonize," Hillman said. "It is genetically stable and should be safe for humans."

Hillman's new strain does not cause disease or predispose the host to other diseases. It also appears to stay permanently on teeth. Hillman said he believes the effector strain can eliminate most tooth decay.

"There is no way to know how much of the world's tooth decay is caused by Streptococcus mutans," Hillman said. "Most studies suggest that of the 500 or so bacterial species in the mouth, Streptococcus mutans causes the majority of decay."

Hillman added that clinical trials would help determine if one application is all that is needed for lifetime protection. The proposed studies will involve squirting a liquid solution of the effector strain on the patients' teeth. He said he hopes to start adult clinical trials this year.

"The ideal application would be to treat infants when their first teeth appear. Infants normally acquire Streptococcus mutans via contaminated saliva from their mother or primary caregiver," Hillman said. "The child would simply visit their dentist for a squirt of solution on their teeth. The approach also is designed for use in older children and adults."

Hillman's effector strain shows promise, said Dennis Mangan, chief of the Infectious Diseases and Immunity Branch at the National Institutes of Health's National Institute of Dental and Craniofacial Research.

"Years of hard work by Dr. Hillman and other oral researchers are coming to fruition. The mechanisms by which bacteria adhere to and grow on the teeth as biofilm communities, and then convert sugar to acids that damage the enamel, after enamel are extremely complicated," Mangan said. "Dr. Hillman's work exploits this knowledge in a clever, yet scientifically feasible manner and takes us one step closer to the day when everyone will be free from dental caries throughout their lifetime."

Don't toss those toothbrushes. Even if Hillman's new strain is successful, it will never replace a good toothbrushing.

"Good dental hygiene will always be necessary because of plaque buildup," Hillman said.

A National Health Spending Trends report indicates that $48 billion was spent on dental services in 1996. Hillman says the future treatment would result in dramatic savings for patients.

For the past 20 years, the National Institute of Dental and Craniofacial Research has funded Hillman's research, which has resulted in a number of product patenting and licensing agreements. OraGen, a biotechnology company located in Alachua, Fla., is licensing the new UF technology.


Story Source:

The above story is based on materials provided by University Of Florida Health Science Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Florida Health Science Center. "UF Dental Researcher Develops Genetically Altered Bacteria Strain That May Fight Cavities For A Lifetime." ScienceDaily. ScienceDaily, 9 February 2000. <www.sciencedaily.com/releases/2000/02/000208135134.htm>.
University Of Florida Health Science Center. (2000, February 9). UF Dental Researcher Develops Genetically Altered Bacteria Strain That May Fight Cavities For A Lifetime. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2000/02/000208135134.htm
University Of Florida Health Science Center. "UF Dental Researcher Develops Genetically Altered Bacteria Strain That May Fight Cavities For A Lifetime." ScienceDaily. www.sciencedaily.com/releases/2000/02/000208135134.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins